SGHT Sight Sciences, Inc. Common Stock
XNAS
9.00
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
SGHT
$9.00
—
Key stats
$9.00
- 52-Week Range
- $3.38 – $9.71
- YTD
- +20.32%
- IV Rank (30D)
- 17.03
- Straddle Price
- $1.57
- P/C Vol Ratio
- 1.67
- Market Cap
- $0.5B
- Open
- $8.97
- Day Range
- $8.88 – $9.18
- Volume
- 267,955
- Prev Close
- $8.99
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 1.66 |
| Cost of Equity (CAPM) | 14.10% (VRP-adj) |
| WACC | 13.71% |
| Volatility Risk Premium | +127.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +17.5% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -56.3% |
| Book / Price | 11.0% |
| Gross Margin (TTM) | 88.0% |
| FCF Margin (TTM) | -28.0% |
| Debt / Equity | 0.58 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $8.51 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $8.75 |
| Bollinger Width / SMA20 | 175.5% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
Peers used for multiples: AVAH, AXSM, BTSG, GH, HRMY, LQDA, MXL, OSCR
60-Day Conviction
94%
20-Day Fair Value
≈ by Nov 25, 2026
$9.20
α +1.9%
rank 84%
conviction
89%
40-Day Fair Value
≈ by Dec 24, 2026
$9.38
α +4.0%
rank 77%
conviction
95%
60-Day Fair Value
≈ by Jan 22, 2027
$9.47
α +5.0%
rank 76%
conviction
94%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 17.4× · 5 peers |
| Peer EV/EBITDA | n/a | 0% | median 18.2× · 6 peers |
| Peer P/B | $10.07 | 50% | median 10.1× · 7 peers |
| Peer P/S | $9.18 | 50% | median 5.3× · 8 peers |
| Market Anchor (SMA50) | $8.51 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $9.49 | 0% | 5 strikes · skew -1.02 |
As of 2026-10-27 · updated
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $0.5B
- Employees
- 186
- List Date
- 2021-07-15
- CIK
- 0001531177
- Next Earnings
- 2026-11-04 (After-Close)
- EPS Forecast
- ($0.12) (4 est.)
- Headquarters
- Menlo Park, CA
- Homepage
- https://www.sightsciences.com
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -18.27% | -6.57% | -16.86% | -21.79% | -16.04% | -15.91% |
| Feb | -- | 19.08% | -4.27% | -4.96% | -2.93% | -19.88% | -2.59% |
| Mar | -- | -33.72% | -20.55% | 28.47% | -4.38% | -32.92% | -12.62% |
| Apr | -- | -39.09% | 14.30% | 4.52% | 33.19% | 11.75% | 4.93% |
| May | -- | 16.55% | -9.36% | 17.35% | 19.81% | 9.21% | 10.71% |
| Jun | -- | 6.52% | -13.39% | -3.89% | 6.17% | 19.38% | 2.96% |
| Jul | 10.36% | -8.48% | 2.21% | 23.30% | -18.18% | -2.23% | 1.16% |
| Aug | -25.27% | -26.17% | -18.66% | -8.76% | 24.16% | 53.71% | -0.17% |
| Sep | -21.04% | -9.42% | -48.47% | 0.16% | -11.11% | 14.29% | -12.60% |
| Oct | 9.72% | 21.77% | -52.97% | -17.49% | 51.04% | -0.11%* | 1.99% |
| Nov | -21.36% | 38.93% | 115.82% | -23.42% | 63.92% | -- | 34.78% |
| Dec | -12.85% | 2.95% | 77.93% | -9.45% | -2.94% | -- | 11.13% |
| Total | -51.03% | -48.00% | -50.67% | -22.85% | 166.88% | 12.79% | 1.19% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $8.75
SMA 50: $8.51
SMA 200: $5.94
Current: $9.02
EMA 12: $8.76
EMA 26: $8.63
MACD: 0.1307 | Signal: 0.0159
BULLISH
ADX (14): 13.84
RANGE
+DI: 24.56
−DI: 18.32
Momentum Oscillators
RSI (14): 57.02
NEUTRAL
Stoch %K: 87.77
Stoch %D: 81.54
Williams %R: -16.90
Volume & Volatility
BB Upper: $9.42
BB Lower: $8.08
NEUTRAL
OBV: 2,180,121
Vol SMA 20: 335,932
Vol ROC: -23.16%
ATR: $0.46
True Range: $0.30
HV 20: 60.2%
HV 30: 53.8%
HV 60: 67.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report - SGHT
Executive Summary
BULLISH (Confidence Level: 8/10)
Key drivers:
- Positive news sentiment around Sight Sciences' OMNI System addition to UnitedHealthcare's covered glaucoma surgery procedures
- Strong technical signals, including a bullish MACD crossover and neutral Bollinger Bands position
- High volatility, indicating potential for significant price movements
Primary risks:
- High beta (1.84) relative to the market, suggesting increased volatility and sensitivity to market movements
- Recent insider selling activity by CFO Alison Bauerlein may indicate caution or profit-taking
2-3 sentence investment thesis: SGHT is a high-risk, high-reward opportunity with potential for significant price appreciation driven by positive news sentiment and strong technical signals. However, the stock's high beta and recent insider selling activity require careful consideration of risk management strategies.
Recent news sentiment impact: The recent positive news headlines have contributed to a bullish sentiment around SGHT, with investors likely anticipating further growth and expansion opportunities for the company.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Uptrend; Medium-term (1-3 months): Uptrend; Long-term (3-12 months): Neutral
Support/Resistance Levels:
- Resistance: $8.63 (upper Bollinger Band), $9.00 (next SMA 20 level)
- Support: $7.95 (lower Bollinger Band), $7.50 (previous low)
Momentum Signals:
- RSI interpretation: Neutral (59.07), indicating a lack of overbought or oversold conditions
- MACD signal: Bullish crossover, suggesting continued upward momentum
- Bollinger Bands position: Neutral, indicating a lack of significant price movements
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 234807.15 (indicating moderate volume)
- On-Balance Volume (OBV): 66548.55 (indicating upward momentum)
- Volume Rate of Change: -1.80% (suggesting a decline in recent trading activity)
News & Sentiment Analysis
Recent Headlines Summary: The past 10 news articles have primarily focused on Sight Sciences' OMNI System and TearCare procedure, highlighting positive results and expansion opportunities.
Sentiment Assessment: Aggregate sentiment is POSITIVE, driven by the recent news headlines and technical signals.
Catalyst Identification: Upcoming events include the company's second-quarter financial report on August 1, 2024, which may provide further insight into the company's growth prospects. Additionally, the release of new product information or partnerships could drive future price movements.
Market Narrative: The positive news sentiment and technical signals are aligning with each other, suggesting a potential uptrend continuation. However, caution is required due to the stock's high beta and recent insider selling activity.
Risk & Volatility Assessment
Beta Interpretation: High risk relative to the market (beta >1.2), indicating increased volatility and sensitivity to market movements.
Volatility Regime: Current vs historical volatility levels:
- Historical volatility: 68.2% (HV60)
- IV Premium vs HV30: 90.5% (positive, suggesting implied richer than realized)
Options Market Signals:
- IV Rank: 23.1% (Low), indicating historically low volatility
- Current IV: 151.3% (High), suggesting high volatility
- Expected Move: $3.50 (38 DTE), 7-DTE: $2.88
Downside Protection: Support levels and risk management considerations:
- Critical price level: $7.95 (lower Bollinger Band)
- Breakout/Breakdown Levels: Resistance at $8.63, support at $7.95
- Time-sensitive catalysts: Upcoming earnings report on August 1, 2024
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- Sector performance: Positive (Dry Eye Treatment Devices)
- Market positioning: Bullish sentiment around SGHT and the sector
Institutional Activity: Volume patterns suggesting institutional interest signals:
- Recent institutional buying or selling activity not evident from available data
- On-Balance Volume (OBV) indicating upward momentum
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- R-squared: 0.28, indicating moderate correlation with the market
Relative Valuation: Position within trading range:
- Current price: $8.10
- Previous high: $9.00 (next SMA 20 level)
- Trading range: $7.50-$9.00
Generated
News
All SGHT news →
Earnings History
14 of 17 under expected move
Avg Expected Move
39.69%
Avg Actual Move
8.61%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2022-08-11 | After-Close | 36.19% | 1.02% | 0.03x | Within |
| 2022-11-10 | After-Close | 8.37% | 34.93% | 4.17x | Exceeded |
| 2023-03-13 | After-Close | 2.13% | 3.30% | 1.55x | Exceeded |
| 2023-05-04 | After-Close | 21.09% | 6.28% | 0.30x | Within |
| 2023-08-03 | After-Close | 13.81% | 7.59% | 0.55x | Within |
| 2023-11-07 | After-Close | 31.43% | 1.90% | 0.06x | Within |
| 2024-03-07 | After-Close | 20.22% | 6.09% | 0.30x | Within |
| 2024-08-01 | Pre-Market | 24.74% | 4.63% | 0.19x | Within |
| 2024-11-07 | After-Close | 33.65% | 9.62% | 0.29x | Within |
| 2025-01-14 | After-Close | 19.05% | 1.27% | 0.07x | Within |
| 2025-05-08 | After-Close | 23.93% | 1.65% | 0.07x | Within |
| 2025-08-07 | After-Close | 92.96% | 19.44% | 0.21x | Within |
| 2025-11-06 | After-Close | 14.00% | 16.40% | 1.17x | Exceeded |
| 2026-01-13 | After-Close | 71.74% | 0.88% | 0.01x | Within |
| 2026-03-04 | Pre-Market | 158.75% | 2.85% | 0.02x | Within |
| 2026-05-06 | Pre-Market | 46.77% | 0.69% | 0.01x | Within |
| 2026-08-05 | After-Close | 55.86% | 27.75% | 0.50x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
SGHT Options Activity & IV Rank
SGHT IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 112.2%
7-DTE IV: —
Expected Move: $1.57
7-DTE Move: $1.57
Days to Exp: 25 (2026-11-20)
Options Flow
Call Volume: 9
Put Volume: 15
P/C Volume: 1.667
BEARISH
Call OI: 115
Put OI: 19
P/C OI: 0.165
Total OI: 134
ATM Options Pricing
ATM Call: $0.50
ATM Put: $1.07
Call %: 5.6%
Put %: 11.9%
Chain Summary
Chain Volume: 113
Chain OI: 410
Last Updated: 10/26/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 52nd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
52%
vs own history
GEX tilt
+1.00
OI-weighted, today
Vanna tilt
+0.86
δ-sensitivity to IV
Charm tilt
-0.38
δ-decay vs time
Vanna tilt +0.86: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.38: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 3 ATM contracts, 0k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · ATM 41.2% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)17.0LowOct 26
Straddle Price (30 DTE)$1.57Oct 26
Beta Analysis
Risk Metrics
Beta: 1.6444
Alpha: 60.46%
Correlation: 0.2771
R-Squared: 7.7%
Stock Volatility: 75.6%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own SGHT
5 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $1.2M | #3513 of 6285 | +59.9% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $1.2M | #2244 of 3138 | -27.5% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $408K | #3249 of 3716 | -71.0% | 13F | |
| Point72 Hedge fund Steve Cohen | $87K | #1841 of 1945 | -83.7% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $1K | #4544 of 4729 | -72.7% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
SGHT Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 53,243,806 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
SGHT Insider Trading (Form 4)
Latest: 2026-10-05Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Paul Badawi | President and CEO | Sell (S) | −29,653 | $9.05 | -$268.3K | EDGAR |
| 2026-10-05 | Brenton Taylor | EVP, Operations & R&D | Sell (S) | −2,988 | $8.85 | -$26.5K | EDGAR |
| 2026-10-05 | James Rodberg | Chief Financial Officer | Sell (S) | −7,208 | $8.85 | -$63.8K | EDGAR |
| 2026-10-05 | David Badawi | Chief Technology Officer | Sell (S) | −7,797 | $9.05 | -$70.6K | EDGAR |
| 2026-10-05 | Alison Bauerlein | Chief Operating Officer | Sell (S) | −25,260 | $8.85 | -$223.6K | EDGAR |
| 2026-08-18 | Kashif Rashid | Chief Legal Officer | Award (A) | +181,818 | — | EDGAR | |
| 2026-07-06 | Brenton Taylor | EVP, Operations & R&D | Sell (S) | −2,829 | $5.42 | -$15.3K | EDGAR |
| 2026-07-06 | Alison Bauerlein | Chief Operating Officer | Sell (S) | −24,184 | $5.36 | -$129.6K | EDGAR |
| 2026-07-06 | James Rodberg | Chief Financial Officer | Sell (S) | −6,902 | $5.36 | -$37.0K | EDGAR |
| 2026-07-06 | Jeremy B. Hayden | Chief Legal Officer | Sell (S) | −12,733 | $5.51 | -$70.1K | EDGAR |
| 2026-07-06 | Paul Badawi | President and CEO | Sell (S) | −28,684 | $5.42 | -$155.5K | EDGAR |
| 2026-07-06 | David Badawi | Chief Technology Officer | Sell (S) | −7,418 | $5.51 | -$40.9K | EDGAR |
| 2026-06-11 | Staffan Encrantz | Director | Buy (P) | +14,100 | $4.88 | $68.8K | EDGAR |
| 2026-06-05 | Gerhard F Burbach | Director | Award (A) | +28,261 | — | EDGAR | |
| 2026-06-05 | Donald Zurbay | Director | Award (A) | +28,261 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
SGHT Insider Holdings
16 insiders · @ $9.02
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Staffan Encrantz | Director | 6,521,203 | $58.82M | $32.60M | 21 | 2026-06-11 |
| 2 | Paul Badawi | President and CEO | 6,092,819 | $54.96M | -$1.61M | 23 | 2026-10-05 |
| 3 | David Badawi | Chief Technology Officer | 1,975,075 | $17.82M | -$413.3K | 28 | 2026-10-05 |
| 4 | Matthew Link | Chief Commercial Officer | 832,293 | $7.51M | -$521.5K | 7 | 2025-07-07 |
| 5 | Alison Bauerlein | Chief Operating Officer | 639,449 | $5.77M | -$1.19M | 19 | 2026-10-05 |
| 6 | Jeremy B. Hayden | Chief Legal Officer | 357,037 | $3.22M | -$878.5K | 23 | 2026-07-06 |
| 7 | Brenton Taylor | EVP, Operations & R&D | 261,990 | $2.36M | -$160.8K | 9 | 2026-10-05 |
| 8 | James Rodberg | Chief Financial Officer | 216,829 | $1.96M | -$203.5K | 9 | 2026-10-05 |
| 9 | Donald Zurbay | Director | 193,613 | $1.75M | $0 | 5 | 2026-06-05 |
| 10 | Kashif Rashid | Chief Legal Officer | 181,818 | $1.64M | $0 | 1 | 2026-08-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
SGHT Board & Officers
As of SEC filings through Oct 5, 2026Directors 8
- David Badawi · since Jul 14, 2021
- Donald Zurbay · since Jul 14, 2021
- Paul Badawi · since Jul 14, 2021
- Staffan Encrantz · since Jul 14, 2021
- Brenda Jane Larsen-Becker · since Mar 15, 2022
- Tamara Fountain · since Jul 15, 2022
- Catherine Mazzacco · since Jun 8, 2023
- Gerhard F Burbach · since Apr 21, 2025
Officers 6
- Paul Badawi · President and CEO · since Jul 14, 2021
- James Rodberg · Chief Financial Officer · listed since Nov 2025
- Alison Bauerlein · Chief Operating Officer · listed since Nov 2025
- David Badawi · Chief Technology Officer · since Jul 14, 2021
- Kashif Rashid · Chief Legal Officer · since Aug 10, 2026
- Brenton Taylor · EVP, Operations & R&D · listed since Sep 2025
10% owners 2
- Paul Badawi · listed since Oct 2025
- Staffan Encrantz · listed since May 2022
Changes in the last 10 years (52)
| Aug 10, 2026 | Kashif Rashid became Chief Legal Officer |
| Aug 6, 2026 | The company announced the departure of Jeremy B. Hayden as Chief Legal Officer in an SEC filing |
| Nov 13, 2025 | Alison Bauerlein listed as Chief Operating Officer (previously Chief Financial Officer) in SEC filings |
| Nov 6, 2025 | James Rodberg listed as Chief Financial Officer (previously Interim Chief Financial Officer) in SEC filings |
| Nov 4, 2025 | The company announced the departure of Erica J. Rogers from the board in an SEC filing |
| Oct 3, 2025 | Paul Badawi first listed as a 10% owner in an SEC filing |
| Sep 3, 2025 | Brenton Taylor listed as EVP, Operations & R&D (previously EVP, Operations) in SEC filings |
| Aug 31, 2025 | Matthew Link left as Chief Commercial Officer, per their own SEC filing |
| Aug 31, 2025 | Manohar K. Raheja left as EVP, Research & Development, per their own SEC filing |
| Apr 21, 2025 | Gerhard F Burbach became a director |
| Nov 4, 2024 | Manohar K. Raheja became EVP, Research & Development |
| Nov 4, 2024 | Brenton Taylor became EVP, Operations |
| Nov 1, 2024 | The company announced the departure of Sam Boong Park as Chief Operating Officer in an SEC filing |
| Feb 16, 2024 | Alison Bauerlein listed as Chief Financial Officer (previously Chief Financial Officer and Treasurer) in SEC filings |
| Dec 29, 2023 | Daniel S. Sundheim reported in an SEC filing no longer being a 10% owner |
| Dec 29, 2023 | D1 Capital Partners L.P. reported in an SEC filing no longer being a 10% owner |
| Sep 11, 2023 | Matthew Link became Chief Commercial Officer |
| Jun 8, 2023 | Catherine Mazzacco became a director |
| Apr 3, 2023 | Alison Bauerlein became Chief Financial Officer and Treasurer |
| Jan 8, 2023 | James Rodberg became Interim Chief Financial Officer |
| Jan 5, 2023 | The company announced the departure of Mack H. Hicks from the board in an SEC filing |
| Jan 5, 2023 | The company announced the departure of Jesse Selnick as Chief Financial Officer in an SEC filing |
| Jul 15, 2022 | Tamara Fountain became a director |
| May 17, 2022 | Staffan Encrantz first listed as a 10% owner in an SEC filing |
| Mar 15, 2022 | Brenda Jane Larsen-Becker became a director |
| Feb 28, 2022 | The company announced the departure of Andrew Offer from the board in an SEC filing |
| Feb 11, 2022 | Paul Badawi no longer listed as a 10% owner in SEC filings |
| Jul 14, 2021 | Valeska Schroeder became a director |
| Jul 14, 2021 | Thomas O Hicks became a 10% owner |
| Jul 14, 2021 | Staffan Encrantz became a director |
| Jul 14, 2021 | Shawn O'Neil became Chief Commercial Officer |
| Jul 14, 2021 | Sam Boong Park became Chief Operating Officer |
| Jul 14, 2021 | Paul Badawi became a director |
| Jul 14, 2021 | Paul Badawi became a 10% owner |
| Jul 14, 2021 | Paul Badawi became President and CEO |
| Jul 14, 2021 | Mack H. Hicks became a director |
| Jul 14, 2021 | Mack H. Hicks became a 10% owner |
| Jul 14, 2021 | Kck Ltd. became a 10% owner |
| Jul 14, 2021 | Jesse Selnick became Chief Financial Officer |
| Jul 14, 2021 | Jeremy B. Hayden became Chief Legal Officer |
| Jul 14, 2021 | HH-IOP Partners, L.P. became a 10% owner |
| Jul 14, 2021 | HH Sight Partners, L.P. became a 10% owner |
| Jul 14, 2021 | HH Sight Partners GP, L.P. became a 10% owner |
| Jul 14, 2021 | HH Sight LLC became a 10% owner |
| Jul 14, 2021 | HEP Partners LLC became a 10% owner |
| Jul 14, 2021 | Erica J. Rogers became a director |
| Jul 14, 2021 | Donald Zurbay became a director |
| Jul 14, 2021 | David Badawi became a director |
| Jul 14, 2021 | David Badawi became Chief Technology Officer |
| Jul 14, 2021 | Daniel S. Sundheim became a 10% owner |
| Jul 14, 2021 | D1 Capital Partners L.P. became a 10% owner |
| Jul 14, 2021 | Andrew Offer became a director |
Not reported recently (10)
- Valeska Schroeder · Last reported as a director in an SEC filing dated Jun 12, 2023
- Mack H. Hicks · Last reported as a 10% owner in an SEC filing dated Aug 5, 2022
- HH Sight LLC · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- HH-IOP Partners, L.P. · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- Thomas O Hicks · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- HH Sight Partners GP, L.P. · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- HH Sight Partners, L.P. · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- HEP Partners LLC · Last reported as a 10% owner in an SEC filing dated Jul 8, 2022
- Shawn O'Neil · Last reported as Chief Commercial Officer in an SEC filing dated Feb 11, 2022
- Kck Ltd. · Last reported as a 10% owner in an SEC filing dated Jul 20, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
SGHT Proposed Insider Sales (Form 144)
Latest: 2026-10-02
? Form 144 Guide
Last 30d:
7 filings
· $886K notice value
· Last 90d:
14 filings
· $1.9M notice value
· 6 unique filers
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
HAYDEN JEREMY B. (9, $1.3M) · Badawi Paul (1, $268K) · Bauerlein Alison (1, $224K) · Badawi David (1, $71K) · Rodberg James (1, $64K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | Bauerlein Alison | Officer | 25,260 | $223.6K | 2026-10-02 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-10-02 | Taylor Brenton | Officer | 2,988 | $26.5K | 2026-10-02 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-10-02 | Rodberg James | Officer | 7,208 | $63.8K | 2026-10-02 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-10-01 | Badawi Paul | Officer, Director | 29,653 | $268.3K | 2026-10-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-10-01 | Badawi David | Officer, Director | 7,797 | $70.6K | 2026-10-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-10-01 | HAYDEN JEREMY B. | Former Officer | 2,746 | $24.8K | 2026-10-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-30 | HAYDEN JEREMY B. | Former Officer | 22,254 | $208.1K | 2026-09-30 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-04 | HAYDEN JEREMY B. | Former Officer | 12,219 | $101.3K | 2026-09-04 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-01 | HAYDEN JEREMY B. | Former Officer | 13,253 | $110.0K | 2026-09-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-17 | HAYDEN JEREMY B. | Former Officer | 12,014 | $97.8K | 2026-08-17 | Fidelity Brokerage Services LLC | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
25 ETFs hold SGHT
25 shown · $36.16M total exposure · 0.02% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $10.7M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $9.0M | $74.6B | 2026-10-23 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $4.3M | — | 2026-09-30 |
| 4 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.02% | $3.2M | $13.7B | 2026-10-23 |
| 5 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $2.1M | — | 2026-09-30 |
| 6 | SMLF iShares U.S. Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.05% | $2.0M | $4.2B | 2026-10-23 |
| 7 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $1.3M | — | 2026-10-23 |
| 8 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.09% | $1.1M | $1.2B | 2026-10-23 |
| 9 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.00% | $794,732 | — | 2026-05-31 |
| 10 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.01% | $752,193 | — | 2026-10-23 |
| 11 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.02% | $405,681 | — | 2026-09-30 |
| 12 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $170,875 | — | 2026-10-26 |
| 13 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $97,200 | — | 2026-05-31 |
| 14 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $38,507 | — | 2026-09-30 |
| 15 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $30,449 | $2.4B | 2026-10-23 |
| 16 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $24,030 | — | 2026-10-23 |
| 17 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.01% | $20,295 | — | 2026-10-26 |
| 18 | URTY ProShares UltraPro Russell2000 | ProShares | 0.01% | $15,569 | — | 2026-10-26 |
| 19 | UWM ProShares Ultra Russell2000 | ProShares | 0.01% | $10,923 | — | 2026-10-26 |
| 20 | MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF | Nport | 0.00% | $7,523 | — | 2026-05-31 |
| 21 | FSEG Fidelity Enhanced Small Cap Growth ETF | Fidelity | 0.10% | $7,282 | $7.6M | 2026-10-23 |
| 22 | AVTM Avantis Total Equity Markets ETF | Avantis | 0.00% | $3,452 | $771.8M | 2026-10-23 |
| 23 | HDG ProShares Hedge Replication ETF | ProShares | 0.00% | $433 | — | 2026-10-26 |
| 24 | RB ProShares Russell 2000 Dynamic Buffer ETF | ProShares | 0.01% | $135 | — | 2026-10-26 |
| 25 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $90 | — | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-0.56
TTM Revenue
$83.38M
TTM Net Income
$-29.76M
TTM Op. Cash Flow
$-23.24M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $23.39M | $-4.45M | $-0.08 | $-5.66M |
| Q1 '26 | 2026-03-31 | $19.70M | $-12.98M | $-0.24 | $-7.03M |
| Q4 '25 | 2025-12-31 | $20.39M | $-4.16M | $-0.08 | $-1.83M |
| Q3 '25 | 2025-09-30 | $19.91M | $-8.17M | $-0.16 | $-8.72M |
| Q2 '25 | 2025-06-30 | $19.56M | $-11.94M | $-0.23 | $-7.54M |
| Q1 '25 | 2025-03-31 | $17.51M | $-14.15M | $-0.28 | $-11.61M |
| Q4 '24 | 2024-12-31 | $19.07M | $-11.85M | $-0.24 | $-3.46M |
| Q3 '24 | 2024-09-30 | $20.16M | $-11.07M | $-0.22 | $362.00K |
| Q2 '24 | 2024-06-30 | $21.37M | $-12.33M | $-0.25 | $-9.47M |
| Q1 '24 | 2024-03-31 | $19.27M | $-16.27M | $-0.33 | $-9.79M |
| Q4 '23 | 2023-12-31 | $18.75M | $-10.69M | $-0.22 | $-6.48M |
| Q3 '23 | 2023-09-30 | $20.01M | $-13.04M | $-0.27 | $-9.83M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
9.08
P/S
5.76
EV/EBITDA
—
EV/Sales
5.17
ROE
-56.3%
ROA
-28.4%
Div Yield
0.00%
FCF Yield
-4.84%
Debt/Equity
0.58
Current Ratio
—
Market Cap
$480.26M
as of 2026-10-26
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
1.42M
SI % of Float
3.84%
Days to Cover
4.13
Short Vol Ratio
42.5%
Free Float
36.87M
Float %
66.9%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-14